HTG Molecular Diagnostics Reports First Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
HTG Molecular Diagnostics (HTGM) Reports Q1 Loss of $0.22/Share
May 10, 2018 4:43 PM EDTHTG Molecular Diagnostics (NASDAQ: HTGM) reported Q1 EPS of ($0.22), versus ($0.73) reported last year. Revenue for the quarter came in at $4.2 million, versus $1.37 million reported last year.
For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.
... More